» Articles » PMID: 39452698

Is Short-Read 16S RRNA Sequencing of Oral Microbiome Sampling a Suitable Diagnostic Tool for Head and Neck Cancer?

Overview
Journal Pathogens
Date 2024 Oct 25
PMID 39452698
Authors
Affiliations
Soon will be listed here.
Abstract

The oral microbiome, studied by sampling the saliva or by oral rinse, has been long thought to have diagnostic capacity for head and neck cancers (HNC). However, previous reports on the HNC oral microbiome provide inconsistent results. The aim of this study is to consolidate these datasets and determine the oral microbial composition between HNC patients to healthy and premalignant individuals. We analyzed 16 published head and neck cancer (HNC) short-read 16S rRNA sequencing datasets, specifically targeting the V3V4, V4 and V4V5 regions. These datasets included saliva and oral rinse samples from donors with HNC, as well as from healthy and premalignant donors. Differences in diversities and microbial abundance were determined. HNC saliva displayed lower alpha diversity than healthy donors. In contrast, the opposite trend was observed for oral rinse samples. Beta diversity scores were largely similar across different patient types. Similar oral phyla were detected for all samples, but proportions were largely dependent on sample type (i.e., saliva or oral rinse) and primer set utilized for 16S rRNA sequencing. , and were elevated in healthy saliva, while was elevated in HNC saliva. Oral rinse and saliva displayed similar enrichment for , while , , and showed conflicting results. The sparse partial least squares discriminant analysis model performed effectively in discriminating HNC from healthy or premalignant patients using V3V4 saliva (AUC = 0.888) and V3V4 oral rinse (AUC = 0.928), while poor discriminative capacity was observed for V4 saliva (AUC = 0.688). In conclusion, our meta-analysis highlighted the limitations of 16S rRNA sequencing, particularly due to variations across study batches, primer sets (i.e., V3V4, V4), and sample types. Hence, caution should be exercised when interpreting 16S rRNA sequencing results across studies, especially when different primer sets and sample types are used.

Citing Articles

A Systematic Review and Meta-Analysis of 16S rRNA and Cancer Microbiome Atlas Datasets to Characterize Microbiota Signatures in Normal Breast, Mastitis, and Breast Cancer.

Rad S, Yeo K, Wu F, Li R, Nourmohammadi S, Tomita Y Microorganisms. 2025; 13(2).

PMID: 40005832 PMC: 11858161. DOI: 10.3390/microorganisms13020467.


The forgotten link: how the oral microbiome shapes childhood growth and development.

Tjandrawinata R, Amalia N, Tandi Y, Athallah A, Afif Wibowo C, Aditya M Front Oral Health. 2025; 6:1547099.

PMID: 39989601 PMC: 11842321. DOI: 10.3389/froh.2025.1547099.

References
1.
Pandey D, Szczesniak M, Maclean J, Yim H, Zhang F, Graham P . Dysbiosis in Head and Neck Cancer: Determining Optimal Sampling Site for Oral Microbiome Collection. Pathogens. 2022; 11(12). PMC: 9785010. DOI: 10.3390/pathogens11121550. View

2.
Chen Z, Wong P, Ng C, Lan L, Fung S, Li J . The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2020; 12(11). PMC: 7698865. DOI: 10.3390/cancers12113425. View

3.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol (Engl Ed). 2021; 74(9):790-799. DOI: 10.1016/j.rec.2021.07.010. View

4.
Chen J, Wu J, Chiang W, Chen Y, Wu W, Wu L . Taxonomic and Functional Dysregulation in Salivary Microbiomes During Oral Carcinogenesis. Front Cell Infect Microbiol. 2021; 11:663068. PMC: 8482814. DOI: 10.3389/fcimb.2021.663068. View

5.
Peter T, Withanage M, Comnick C, Pendleton C, Dabdoub S, Ganesan S . Systematic review and meta-analysis of oral squamous cell carcinoma associated oral microbiome. Front Microbiol. 2022; 13:968304. PMC: 9632422. DOI: 10.3389/fmicb.2022.968304. View